Active surveillance vs treatment for prostate cancer
June 27, 2026 by user
Patient education
Active surveillance vs treatment for prostate cancer
A balanced overview of why some prostate cancers are monitored while others need active treatment.
Quick answer
Some lower-risk prostate cancers can be monitored closely, while higher-risk or changing cancers may need treatment.
What this can mean
Active surveillance aims to avoid or delay treatment side effects when cancer appears unlikely to cause harm in the short term.
Treatment may be advised when the cancer features, PSA trend, MRI or biopsy findings suggest a higher risk of progression.
How specialist assessment may help
- Explain the difference between surveillance and watchful waiting.
- Review risk features and PSA trend.
- Discuss surgery, radiotherapy and other pathways when relevant.
- Set a clear follow-up plan if monitoring is chosen.
Questions to ask at your appointment
- Why am I suitable or unsuitable for surveillance?
- How often would I need PSA or MRI?
- What would trigger treatment?
- What side effects should I consider?
Common questions
Is surveillance doing nothing?
No. It is an active monitoring plan with defined review points.
Can I switch from surveillance to treatment?
Yes, if the cancer changes or if your preferences change.
General information only. It should not replace personalised advice from a qualified clinician. Last updated 27 June 2026.